Novo Nordisk Says Wegovy Improved Patients’ Liver Disease
Novo Nordisk A/S’s Wegovy helped treat an obesity-associated liver disease in a late-stage trial, potentially adding to its ...
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...
Novo Nordisk Shares Seen Outpacing Lilly’s After Summer Stumble
Novo Nordisk A/S has fallen behind Eli Lilly & Co. this year in the race to be the big stock market winner from obesity drugs ...
US FDA says lowest dose of Novo Nordisk's weight-loss drug now available
The lowest dose of Novo Nordisk's weight-loss drug, Wegovy, was listed as available on the U.S. health regulator's website on ...
Novo Nordisk posts Phase 3 win for obesity drug in MASH
Novo Nordisk (NVO) stock gains as its weight loss drug succeeds in Phase 3 trial for the liver disease, MASH hurting Eli ...
FiercePharma1d
Novo Nordisk's semaglutide delivers in phase 3 MASH study, teeing up filings
With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing ...
CVS Health, Apollo Global Management, And Novo Nordisk Reported Results
Stay ahead of the market with Seeking Alpha's Wall Street Week Ahead newsletter, previewing key events like elections, Fed meeting, earnings reports.
Novo Nordisk Reports Positive ESSENCE Trial Results
Novo Nordisk (NVO) has released an update. Novo Nordisk has announced promising results from the first part of its ESSENCE trial, showing that ...
Novo Nordisk’s semaglutide shows superior MASH resolution improvement in trial
Novo Nordisk (NVO) announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, double-blinded trial ...
Novo Nordisk's Weight-Loss Drug Helps Improve Symptoms of Liver Disease, Trial Shows
Novo Nordisk's semaglutide trial showed 62.9% of patients experienced resolution of symptoms with no worsening of scarring. "Novo Nordisk's Weight-Loss Drug Helps Improve Symptoms of Liver Disease, ...
STAT3d
Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA
Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...
FiercePharma2d
Novo Nordisk hit with FDA write-up over production issues at critical semaglutide plant
Novo Nordisk landed in hot water with the FDA following an inspection at one of the drugmaker’s key semaglutide and insulin manufacturing plants this past spring. | The FDA issued a ...